125 related articles for article (PubMed ID: 1331999)
21. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.
Suarez-Roca H; Maixner W
Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103
[TBL] [Abstract][Full Text] [Related]
22. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
Suh HH; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
[TBL] [Abstract][Full Text] [Related]
23. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
Randich A; Robertson JD; Willingham T
Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
Qi JA; Mosberg HI; Porreca F
Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
[TBL] [Abstract][Full Text] [Related]
25. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
Sofuoglu M; Portoghese PS; Takemori AE
Life Sci; 1993; 52(8):769-75. PubMed ID: 8383271
[TBL] [Abstract][Full Text] [Related]
26. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
27. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
28. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.
Paquette NC; Young GA
Eur J Pharmacol; 1991 Apr; 196(1):61-7. PubMed ID: 1678713
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
Mjanger E; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
[TBL] [Abstract][Full Text] [Related]
30. Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice.
Rady JJ; Gorny JM; Fujimoto JM
Jpn J Pharmacol; 1998 Dec; 78(4):443-54. PubMed ID: 9920201
[TBL] [Abstract][Full Text] [Related]
31. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
[TBL] [Abstract][Full Text] [Related]
32. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats.
Hong O; Young GA; Khazan N
Neuropharmacology; 1988 Aug; 27(8):807-12. PubMed ID: 2905786
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.
Hong M; Sutak M; Jhamandas K
Br J Pharmacol; 1993 Apr; 108(4):1137-42. PubMed ID: 8485623
[TBL] [Abstract][Full Text] [Related]
34. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
[TBL] [Abstract][Full Text] [Related]
35. Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception.
Kest B; Lee CE; Jenab S; Kao B; Inturrisi CE
Eur J Pharmacol; 1998 Mar; 345(1):47-53. PubMed ID: 9593593
[TBL] [Abstract][Full Text] [Related]
36. Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.
Chen XH; Liu-Chen LY; Tallarida RJ; Geller EB; de Riel JK; Adler MW
Neurochem Res; 1996 Nov; 21(11):1363-8. PubMed ID: 8947926
[TBL] [Abstract][Full Text] [Related]
37. Enkephalin analog, cyclo[N(ε),N(β)-carbonyl-D-Lys(2),Dap(5)] enkephalinamide (cUENK6), inhibits the ethanol withdrawal-induced anxiety-like behavior in rats.
Gibula-Bruzda E; Marszalek-Grabska M; Witkowska E; Izdebski J; Kotlinska JH
Alcohol; 2015 May; 49(3):229-36. PubMed ID: 25716198
[TBL] [Abstract][Full Text] [Related]
38. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiological actions of delta opioids in CA1 of the rat hippocampal slice are mediated by one delta receptor subtype.
Watson GB; Lanthorn TH
Brain Res; 1993 Jan; 601(1-2):129-35. PubMed ID: 8381696
[TBL] [Abstract][Full Text] [Related]
40. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
Malmberg AB; Yaksh TL
J Pharmacol Exp Ther; 1992 Oct; 263(1):264-75. PubMed ID: 1328610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]